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Abstract
Introduction: Otitis media is an umbrella term for middle ear inflammation; ranging
from acute infection to chronic mucosal disease. It is a leading cause of antimicrobial
therapy prescriptions and surgery in children. Despite this, treatments have changed
little in over 50 years. Research has been limited by the lack of physiological models
of middle ear epithelium.
Methods: We develop a novel human middle ear epithelial culture using an air-liquid
interface (ALI) system; akin to the healthy ventilated middle ear in vivo. We validate
this using immunohistochemistry, immunofluorescence, scanning and transmission
electron microscopy, and membrane conductance studies. We also utilize this model
to perform a pilot challenge of middle ear epithelial cells with SARS-CoV-2.
Results: We demonstrate that human middle ear epithelial cells cultured at an ALI
undergo mucociliary differentiation to produce diverse epithelial subtypes including
basal (p63+), goblet (MUC5AC+, MUC5B+), and ciliated (FOXJ1+) cells. Mature
ciliagenesis is visualized and tight junction formation is shown with electron micros-
copy, and confirmed by membrane conductance. Together, these demonstrate this
model reflects the complex epithelial cell types which exist in vivo. Following SARS-
CoV-2 challenge, human middle ear epithelium shows positive viral uptake, as mea-
sured by polymerase chain reaction and immunohistochemistry.
Conclusion: We describe a novel physiological system to study the human middle
ear. This can be utilized for translational research into middle ear diseases. We also
demonstrate, for the first time under controlled conditions, that human middle ear
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epithelium is susceptible to SARS-CoV-2 infection, which has important clinical impli-
cations for safe otological surgery.
Level of Evidence: NA.
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1 | INTRODUCTION
Inflammation of the middle ear, known generally as otitis media (OM),
represents a spectrum of disease. This can be initiated by an acute
infection in acute otitis media and may lead to a persistent accumula-
tion of fluid in the middle ear cavity in otitis media with effusion or to
chronic suppurative otitis media when associated with a perforated
tympanic membrane.
The burden of OM is substantial. It is one of the largest causes
of infections and surgery in childhood1 and OM-related hearing loss
affects 30 per 10 000 people.2 Despite the substantial morbidity of
OM, few in vitro models of middle ear epithelium exist. Air-liquid
interface (ALI) cultures are well established for the generation of
physiological models of airway epithelium from much of the respira-
tory tract, but application of this technique to the human middle ear
is lacking. A comprehensive cellular model of middle ear epithelium
which recapitulates key features of differentiated cell types will
facilitate translational research into OM and related middle ear
diseases.
Viral infection is a common cause of OM. Little is known, how-
ever, about the effect of SARS-CoV-2 on middle ear epithelium and
whether this can induce OM akin to other viruses. We aim to perform
a pilot exploration, utilizing this physiological human model of middle
ear epithelium, to assess middle ear susceptibility to SARS-CoV-2
infection.
2 | METHODS
2.1 | Tissue acquisition
Human fetal middle ear epithelium (n = 1; 14 post conception
weeks) was obtained from the MRC/Wellcome Trust-funded
Human Developmental Biology Resource (HDBR; http://www.
hdbr.org) with written consent and approval from the Newcastle
and North Tyneside NHS Health Authority Joint Ethics Committee
(08/H0906/21 + 5). HDBR is regulated by the UK Human Tissue
Authority (HTA; www.hta.gov.uk) and operates in accordance with
the relevant HTA Codes of Practice to provide human fetal tissue
from 3 to 20 post conception weeks for biomedical research.
Quantitative fluorescent polymerase chain reaction (PCR) was
used to exclude common aneuploidies. The temporal bone was
micro-dissected to identify the middle ear cavity and middle ear
mucosal tissue was extracted.
2.2 | Air-liquid interface cultures
The tissue was dissociated into a cell suspension and passed through
a 100-μm cell strainer (Greiner Bio-One, Kremsmünster, Austria) and
centrifuged. Cells were seeded onto a collagen-coated flask with
PneumaCult-Ex Plus (Stemcell Technologies) and cultured in a humidi-
fied atmosphere containing 5% CO2 at 37
C. Cells were expanded
over 7 to 10 days with media changes every 48 to 72 hours.
Upon reaching, 70% confluence cells were passaged onto Costar
transwell membranes (Sigma Aldrich, St Louis, Missouri), with 0.4 μm
pore size, pre-coated with collagen. Cells underwent expansion in the
transwell system using PneumaCult-Ex Plus (Stemcell Technologies)
for 4 days with media supplied to both the apical and basolateral com-
partments. On day 4, the media was removed from the apical
compartment and the cells were exposed to air on their apical
surface only. After 4 weeks, cultures underwent subsequent valida-
tion experiments.
2.3 | Immunohistochemistry
Transwell membranes were fixed in 4% paraformaldehyde. The speci-
men was dehydrated through graded ethanol baths, infiltrated with
paraffin wax, and embedded into paraffin blocks at 60C. The tissue
blocks were then sectioned at 5-μm thickness using an RM2235
Microtome (Leica). The Ventana Discovery Autostainer (Ventana,
Tucson, Arizona) was used for immunohistochemistry (IHC) following
the manufacturer's instructions.
2.4 | Immunofluorescence
The transwell membranes were washed and fixed in 4% paraformalde-
hyde, permeabilized with 0.3% Triton and blocked with 5% bovine
serum albumin and incubated with the primary and secondary anti-
bodies (Supporting Information S1) as previously described.3
Transwell scaffolds were then fixed to glass slides and imaged on an
Axioimager without immersion (Zeiss, Oberkochen, Germany).
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2.5 | Transmission electron microscopy
Membrane-bound epithelial cells were fixed, dehydrated, and impregnated
with increasing concentrations of epoxy resin. They were then polymer-
ized at and sections were cut on an ultramicrotome (70 nm). Sections
were stained with 1% uranyl acetate and 2% lead citrate on an EM AC20
automatic staining machine (Leica) before being viewed on a Hitachi
HT7800 transmission electron microscope as described previously.4
2.6 | Scanning electron microscopy
Membrane-bound epithelial cells were fixed in 2.5% glutaraldehyde,
dehydrated in graded ethanol, and placed in a Baltec CPD 030 critical
point dryer (Leica), gold coated and observed under a Tescan VEGA
LMU SEM microscope (Tescan, Cambridge, UK) as described
previously.4
2.7 | Cell membrane barrier function and ion
channel characterization
Epithelial integrity and ion transport was evaluated using short-circuit
current measurements using selective ion channel inhibitors in an
Ussing chamber (VCC MC 8 model, Physiologic Instruments, California).
The membrane-bound epithelial cells were inserted into the EasyMount
Ussing chamber system and bathed in bilateral modified bicarbonate
Kreb's solution, continuously gassed with 95% O2/5% CO2 maintained
at 37C. Cells were voltage-clamped to 0 mV and left to equilibrate
before adding the inhibitors and agonists, which were added in the fol-
lowing order: amiloride (10 μM apical; Sigma-Aldrich), forskolin (10 μM,
bilateral; Tocris Bioscience, Bristol, UK), CFTRinh172 (20 μM, apical;
Tocris Bioscience). The transepithelial short-circuit current (Isc) and
transepithelial electrical resistance were measured using Ag and
Ag/AgCl electrodes with 3 M KCl agar bridges and recorded using the
Acquire & Analyze software Revision II (Physiologic Instruments). The
assay was simultaneously run with duplicate samples.
2.8 | SARS-CoV-2 Infection
A clinical isolate of SARS-CoV-2 (England/2/2020) was obtained from
Public Health England. The initial viral stock was propagated in Vero
E6 cells as previously described.5 Infections were performed in a con-
tainment level 3 facility. 2  105 pfu of SARS-CoV-2 was added to
the apical side of two wells of middle ear epithelial cells differentiated
at an ALI and one well of confluent Vero E6 cells (passage 10). Two
wells of middle ear epithelium and one well of Vero E6 cells were left
untreated (mock control).
All samples were incubated (37C/5% CO2) for 2 hours. Subse-
quently, the samples were washed and fresh media added. The cells
were returned to the incubator until cell collection.
2.9 | Quantitative Reverse Transcription (RT) PCR
Mock and SARS-CoV-2 infected cells were lysed with Trizol reagent
(Invitrogen) for RNA extraction, with resultant RNA being reverse
transcribed with Superscript III (ThermoFisher Scientific) according to
manufacturer's instructions. cDNA templates underwent qPCR as pre-
viously described.6
Two PCR probes against the SARS-CoV-2 nucleocapsid (N) genes
(N1/N2) were tested using the 2019-nCoV RUO kit (Integrated DNA
Technologies, Coralvillle, Iowa) in accordance with manufacturer's
instruction. The qPCR was then run using an AriaMx real-time PCR
system (Agilent Technologies, California). Expression was determined
by ddCT where the nucleocapsid expression was normalized to the
endogenous housekeeping gene, RNAseP, and duplicate samples
averaged.
Tissue preparation and IHC for anti-SARS-CoV-2 was performed
as outlined in the earlier methods using the anti-SARS-CoV-2 spike
protein antibody (Sino-Biological, Beijing, China; 40 589-T62).
3 | RESULTS
3.1 | Air-liquid interface cultures
On the first and only attempt at running these cultures middle ear epi-
thelial cells were observed to form discrete islands in the days follow-
ing initiation of submerged culture which gradually connected one
another from approximately day 7. A typical epithelial “cobblestone”
morphology was witnessed as cells approached confluence at approxi-
mately 14 days.
Once cultured at an ALI cells underwent mucociliary differentia-
tion over a period of 4 weeks. After this time, they were used for cell
characterization and further experiments. Macroscopically, the pro-
duction of airway surface liquid was evident as a slim meniscus cover-
ing the transwell. Conventional light microscopy revealed a dense
population of epithelial cells (Figure 1) with isolated areas of motile
cilia (Supporting Information S2).
3.2 | Immunohistochemistry
IHC revealed strongly positive staining for FOXJ1, moderate positivity
in MUC5AC and MUC5B, and mildly positive staining with SPLUNC1
and cytokeratin (Figure 2).
3.3 | Immunofluorescence
Immunofluorescence (Figure 3) revealed scattered positive staining
with cytokeratin 14/16. There was strong positive staining with
MUC5AC, p63, and FOXJ1. Little positivity was observed with
SPLUNC and MUC5B.
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3.4 | Electron microscopy
Scanning electron microscopy (SEM) reveals a surface with moderately
dense cilia coverage (Figure 4). Transmission electron microscopy (TEM;
Figure 4B) similarly demonstrates cilia (green arrow) and also the pres-
ence of tight junctions (red arrow).
3.5 | Ussing chamber
Tight epithelial junctions were confirmed by resistance measurements
on Ussing chamber experiments. Selective ion channel inhibitors
(Table 1) were sequentially added to assess individual ion channels;
F IGURE 1 Dense distribution of epithelial cells seen on light
microscopy (20 magnification). Scale bar 50 μm
F IGURE 2 Immunohistochemistry for (top to bottom) MUC5AC,
SPLUNC1, cytokeratin, FOXJ1, and MUC5B
F IGURE 3 (A) Immunofluorescence with cytokeratin 14/16
[green] and MUC5AC [red] (upper left; and upper right), DAPI [blue]
as a nuclear counterstain (bottom left), and the merged staining
(bottom right). Scale bar 100 μm. (B) Immunofluorescence with
SPLUNC [green] and p63 [red] (upper left and upper right), DAPI
[blue] as a nuclear counterstain (bottom left), and the merged staining
(bottom right). Scale bar 100 μm. (C) Immunofluorescence with
MUC5B [green] and FOXJ1 [red] (upper left and upper right), DAPI
[blue] as a nuclear counterstain (bottom left), and the merged staining
(bottom right). Scale bar 100 μm
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revealing an abundance of predominantly ENaC and CFTR trans-
porters (Figure 5). A mean resting transepithelial electrical resistance
(TEER) of 231.0 Ω cm2 was recorded, consistent with the develop-
ment of epithelial barrier function.
3.6 | SARS-CoV-2 infection
Following exposure of cells to SARS-CoV-2, positivity in both N1 and
N2 gene expression were observed, indicating permissiveness to
infection. The mock experiments showed no evidence of viral nucleo-
capsid expression (Figure 6). IHC with anti-SARS-CoV-2 reveals posi-
tive staining in the test sample but not in the mock control
(Figure 6B).
4 | DISCUSSION
The lack of physiological models of middle ear epithelium has ham-
pered research efforts to understand the pathophysiology of OM and
related middle ear diseases. Much work to date has relied upon animal
models. For example, Mulay et al recently generated a valuable and
well-validated culture of murine middle ear epithelium.7 Although
these have convenient husbandry and offer the ability to make
genetic alterations, they are unlikely to completely reflect human
disease; reasons for this include the lack of homology between animal
and human genetics and also because the uniformity of laboratory
animal models do not reflect the complex environments in which
human diseases manifest.8
The other widely used tool in OM research is the human middle
ear epithelial cell line (HMEEC-1).9 When compared to primary cells
these show marked differences both in baseline expression and
stimuli-induced expression of a range of inflammatory mediators.10
The HMEEC-1 cell line also lacks important phenotypic features, such
as cilia, which have known functional importance, such as mucociliary
transport around the Eustachian tube orifice.
More recently, Chen et al used conditional cell reprogramming in
which a Rho kinase inhibitor was used to induce a stem-like state in
epithelial cells and enable cell proliferation in human middle ear epi-
thelium samples,11 however, a limitation of conditionally rep-
rogrammed cells is that stem-like or transiently expanded cell states
do not reflect important features of differentiated cells.12
Overcoming these limitations would likely accelerate translational
understanding of OM. Although efforts have been made to generate
more physiological models of human middle ear epithelium, these
have largely failed due to the small numbers of cells which are obtain-
able from primary middle ear mucosal biopsies.13
We have overcome this challenge by accessing human fetal
middle ear tissue through an approved developmental biobank
(HDBR; http://www.hdbr.org). The HDBR is a Wellcome Trust and
MRC-funded bioresource, which provides human fetal tissues
(including ENT subsites) from 3 to 20 weeks of development for
approved biomedical research in the UK and abroad in accordance
with the relevant HTA and local governance Codes of Practice. Due
to a larger yield of primary cells, and greater depth of sampling, we
have been able to initiate and sustain traditional submerged cultures
of human middle ear epithelial cells. Furthermore, we have been
able to transfer these to an ALI culture system (similar to the
healthy ventilated middle ear). The resultant cells are of differenti-
ated epithelial phenotypes which recapitulate the middle ear epithe-
lium around the Eustachian tube orifice in vivo suggesting that this
F IGURE 4 (A) Scanning
electron microscopy (SEM)
demonstrating presence of cilia.
(B) Transmission electron
microscopy (TEM) demonstrating
appearances supportive of the
formation of tight junctions (red
arrow) and cilia (green arrow)
TABLE 1 Short circuit current by ion channel inhibitors
Short circuit current (Isc)/μAmp cm2
Transwell 1 Transwell 2 Mean
Amil 76.4 84.9 80.7
FSK 2.6 2.2 2.4
Inhib-172 15.2 18.0 16.6
Abbreviations: Amil, amiloride; FSK, forskolin; Inh-172, inhibitor of cystic
fibrosis transmembrane conductance regulator (CFTR).
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may be a suitable model which, for example, could be used to
study OM.
Specifically, our ALI cultures expressed typical general markers
for epithelial cells (cytokeratin),14,15 basal cells (p63), ciliated cells
(FOXJ1),16 and (mucin) secretory subtypes (MUC5AC, MUC5B)17;
indicating the production of a complex family of cell populations
which more closely resemble the physiological environment in vivo.18
We also examined other markers of known importance, such as
SPLUNC; an antimicrobial peptide ubiquitously expressed in the upper
airways, which showed no positive staining in our cultures. It is possi-
ble that its absence is secondary to the lack of infective stimuli;
indeed, this would be in keeping with the findings of Hadzhiev and
colleagues who identified reduced SPLUNC expression in the middle
ear mucosa of patients undergoing cochlear implantation (ie, non-
infected/inflamed mucosa) compared to those undergoing radical
mastoidectomy for chronic OM with cholesteatoma.19
Middle ear mucosa has a key role in regulating cellular secretion
and absorption of fluid and dysfunction of this process has been impli-
cated in the pathogenesis of OM. To understand the relative roles of
ion transport channels governing fluid transport in these cultures, we
used the Ussing chamber with selective addition of specific channel
activators and inhibitors. This revealed high ENaC function and, to a
lesser extent, CFTR transporters; in keeping with previous characteri-
zation of human middle ear mucosa.20 Although modulation of ENaC
F IGURE 5 (A) Human middle
ear epithelia show ENaC and
CFTR activity. Mean short circuit
current (Isc) measurements over
time from two middle ear
epithelial transwells run in
duplicate. ENaC activity was
measured as a change in Isc (Δisc)
induced by amiloride (Amil,
10 μM, apical). CFTR activity was
measured as change in Isc (ΔIsc)
induced by forskolin (FSK, 10 μM,
bilateral) and CFTRinh172 (Inh-
172, 20 μM, apical). (B) Absolute
mean lsc with the addition of
Amil, FSK, and Inh-172
F IGURE 6 (A) In vitro SARS-
CoV-2 infection of middle ear
epithelium. RT-PCR for SARS-
CoV-2 N1 (left panel) and N2
(right panel) expression in SARS-
COV-2 (black) and mock (grey)
infected middle ear and vero cells
and mock infected cells 24 hours
post infection.
(B) immunohistochemistry (IHC)




(indicated by red arrows) and
lower panel indicating no positive
staining in the mock (negative)
control
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channels with dexamethasone has been trialed in vitro21 treatment of
OM with steroids in clinical trials has to date proved disappointing,22
highlighting the challenges of translating positive findings from cellular
models into clinical practice.
Although OM is typically caused by a select group of
otopathogens,23 the emerging SARS-CoV-2 pandemic raised the
question of whether this novel coronavirus may have a role in OM
and whether the middle ear could represent a clinically occult reser-
voir of viable virus. To date, there is retrospective evidence from post-
mortem examinations that SARS-CoV-2 can be isolated from the
middle ear/mastoid24 and SARS-CoV-2 induced middle ear infection
has also been inferred in clinical case reports, but these lacked pro-
spective definitive microbiological isolation from the middle ear.25
Having successfully characterized our cellular model, this, therefore,
represented a timely and relevant question to explore the potential
utility of our system.
Direct infection of our middle ear culture demonstrated posi-
tive viral uptake as shown both by PCR and IHC. Furthermore, this
positivity was observed at 24 hours post-infection; demonstrating
that middle ear epithelium is permissive to infection with SARS-
CoV-2. The main limitation of this work is that only a single run of
the infection assay was feasible due to limited access to a category
3 laboratory during the COVID-19 pandemic. Assuming generaliz-
ability from this pilot study would suggest several important impli-
cations. First, given that initial SARS-CoV-2 uptake may commonly
be via nasal epithelial cells; it seems probable that transmission of
viral particles to the middle ear is feasible due to the migration via
the Eustachian tube. Therefore, clinical signs and symptoms of OM
could putatively represent middle ear infection with SARS-CoV-2
(COVID-OM). Second, the presence of SARS-CoV-2 residing
within middle ear epithelial cells also gives rise to the possibility of
viral transmission in those exposed to such tissues. This may
include surgical staff in the context of middle ear or mastoid sur-
gery; particularly where the use of high-speed drills could widely
propagate virally infected cells around the operating environ-
ment.26 This supports the need for appropriate personal protective
equipment in otological surgery. Finally, in patients with tympanic
membrane perforations and chronic ear discharge who have been
exposed to SARS-CoV-2, it seems probable that such discharge
could be contaminated with infected middle ear epithelial cells,
and therefore, such clinical specimens ought to be considered
infectious until proven otherwise.
5 | CONCLUSION
Herein, we demonstrate culture of human middle ear epithelial cells at
an ALI, akin to the healthy ventilated middle ear. We comprehensively
validate these findings and use this model to demonstrate for the first
time, the permissiveness of middle ear epithelium to SARS-CoV-2
infection. This has important implications both for safe otological sur-
gery and the possibility of the middle ear harboring SARS-CoV-2
infection.
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